【贝恩公司】2024年ESG对亚太地区医疗技术行业的重要意义研究报告_20页_1mb

Summary

ESG (Environmental, Social, and Governance) factors are increasingly vital in the APAC medical technology (medtech) industry, driven by growing stakeholder expectations from clients, employees, investors, and regulators. A survey shows that over 70% of APAC medtech clients view ESG as a core procurement standard, with many aiming for stricter ESG goals in the next five years, especially in countries like China and Australia.

Key environmental challenges include high carbon emissions from medical supply chains and evolving climate regulations, such as carbon pricing in regions like Singapore, China, and Korea. This requires strong governance and innovative solutions, like reducing waste and improving energy efficiency.

Social aspects highlight employee preferences, with nearly 75% wanting to work for companies reducing environmental harm, and ESG factors gaining prominence in recruitment. Governance involves transparent operations, ethical practices, and compliance with varying APAC regulations.

Opportunities include leading innovation, such as digital health and AI, which can enhance patient care and reduce emissions. Challenges involve adapting to diverse regulatory landscapes in APAC markets, but ESG can drive cost savings and competitive advantage.

Industry-wide action is essential. The APACMed alliance forges partnerships and shares best practices, including an online environmental regulations tracker, to promote collaboration, education, and sustainable initiatives across medtech.

In essence, embracing ESG not only meets growing demands but also creates a path for long-term sustainability and market leadership.